Application Note

The Application Of The Species-Specific Liver-Chip In Predicting Hepatoxicity

Source: Emulate
GettyImages-961746674 3D Illustration of Human Liver Anatomy

An evaluation of 150 drug candidates that caused adverse events in humans revealed that testing solely in rats and dogs predicted only 71% of these toxicities in humans. Of particular concern is the liver, as drug-induced liver injury (DILI) stands as the primary reason for the withdrawal of drugs from the market and throughout the clinical development process.

The Emulate Liver-Chip offers a promising solution to this translational challenge, as it replicates in vivo-relevant liver function within a more physiologically accurate microenvironment compared to conventional cell-based models.

This application note outlines how researchers can leverage the Liver-Chip to anticipate diverse mechanisms of unexpected human toxicity in preclinical drug candidates, evaluate the human relevance of toxicity observed in preclinical animal studies, and decipher the mechanism of toxicity for candidates showing unexpected safety signals in the clinic.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online